Pharmaceutical

Causaly secures $60 Million in series B funding

Causaly serves 12 of the top 20 pharmaceutical companies with technology that aims to expedite the drug discovery process.

Jul 15, 2023 - 20:00
Causaly secures $60 Million in series B funding
Causaly serves 12 of the top 20 pharmaceutical companies with technology that aims to expedite the drug discovery process.
Read the original article

Tags:

Previous Article

Bicycle Therapeutics plans $200m public offering

Next Article

Coherus plans Humira biosimilar sale at 85% discount

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Federal advisory group rejects proposal to make medical device tracking easier

STAT+: Federal advisory group rejects proposal to make ...

Jun 14, 2023

Bristol Myers Squibb’s Reblozyl reinforces market share in first-line MDS Space

Bristol Myers Squibb’s Reblozyl reinforces market share...

Sep 13, 2023

Johnson & Johnson is getting rid of its script logo after more than 130 years

Johnson & Johnson is getting rid of its script logo aft...

Sep 14, 2023